• Explore /
  • Poster
  • / Checkpoint inhibitors in combination with chemotherapy for first-line treatment of advanced squamous non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).

Checkpoint inhibitors in combination with chemotherapy for first-line treatment of advanced squamous non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled trials (RCTs).

Abstract Poster

Authors

null

Aung Tun

Brooklyn Hospital Center, Brooklyn, NY

Aung Tun, Wai Lin Thein, James Gasperino, Aymen Elfiky, Elizabeth Guevara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Immune Checkpoints and Stimulatory Receptors

Citation

J Clin Oncol 37, 2019 (suppl 8; abstr 121)

DOI

10.1200/JCO.2019.37.8_suppl.121

Abstract #

121

Poster Bd #

H5

Abstract Disclosures

Similar Posters

First Author: Aung Tun

First Author: Thierry Landre

First Author: Wai Lin Thein

First Author: Ranjan Pathak